Oba T, Ono M, Matoba H, Uehara T, et al. HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells. Breast Cancer Res Treat 2021 Jan 16. pii: 10.1007/s10549-020-06033.
PMID: 33452951